Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Top 5 Marijuana Stocks for 2019
With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas in the marijuana industry this year.
One of the companies highlighted in this report offers a life-changing therapy that reduces the number of seizures in children with two rare types of childhood-onset epilepsy. It has the potential for the stock to sky-rocket. You need to find out the name of this company before the rest of the market does.
P.S. Not many retail investors pay attention to the marijuana sector. Use this complimentary guide and get a head start on your path to profiting from the booming cannabis industry!
Menu

Enanta Pharmaceutica (ENTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enanta Pharmaceutica 500 ARSENAL STREET WATERTOWN MA 02472 USA

P: 617-607-0800 F: 617-607-0530

Description:

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,734,031
Shares Outstanding, K 19,442
Annual Sales, $ 206,630 K
Annual Net Income, $ 71,960 K
Last Quarter Sales, $ 69,890 K
Last Quarter Net Income, $ 26,010 K
60-Month Beta 1.38
% of Insider Shareholders 11.35%
% of Institutional Shareholders 86.55%
Float, K 17,235
% Float 88.65%

Growth:

1-Year Return 1.42%
3-Year Return 205.45%
5-Year Return 150.89%
5-Year Revenue Growth 544.71%
5-Year Earnings Growth 619.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.25 on 02/06/19
Next Earnings Date 05/07/19
Earnings Per Share ttm 4.13
EPS Growth vs. Prev Qtr -3.85%
EPS Growth vs. Prev Year 60.26%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ENTA Ratios

Ratio
Price/Earnings ttm 20.24
Price/Earnings forward 30.08
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 22.78
Return-on-Assets (Before Tax) 21.54
Profit Margin % 34.83
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 7.87
Price/Cash Flow 22.00
Price/Book 3.81
Book Value/Share 21.96
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar